Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Matthew Hirschtritt MD, MPH

Matthew E. Hirschtritt MD, MPH

Physician, The Permanente Medical Group; Associate Program Director for Research, Kaiser Permanente Oakland Adult Psychiatry Residency Training Program; Adjunct Investigator, Kaiser Permanente Division of Research, Northern California

Dr. Hirschtritt is a Volunteer Assistant Clinical Professor in the UCSF Department of Psychiatry and the UCSF Weill Institute for Neurosciences. He is also an Associate Physician in the Department of Psychiatry of The Permanente Medical Group (Oakland, CA) and an Adjunct Investigator in the Kaiser Permanente Division of Research. The overarching goals of his research include improving equitable access to, quality of, and cost-effectiveness of mental health detection and treatment, focusing on under-served and marginalized communities.

Dr. Hirschtritt's investigative work has involved diverse mental health-related topics, including characteristics and treatments for obsessive-compulsive disorder, Tourette syndrome, adolescent depression and attention-deficit/hyperactivity disorder, and substance use disorders. His work has also examined the interrelationship between adolescent resiliency, peer victimization, and suicidal ideation. More recently, his work has focused on the distribution, provision, and quality of mental health care in the United States, which has involved addressing mental health stigma (specifically the harmful implications of attributing gun violence exclusively to mental illness) and psychotropic prescription patterns using nationally representative data.

Disclosures

No disclosures are reported.